‘Provocative results’ boost hopes of antibody treatment for COVID-19
Regeneron’s monoclonal antibody cocktail reduces viral load in people infected with SARS-CoV-2
Related Articles
News at a glance: Global coral bleaching, preventing ship strikes on whales, and detecting prostate cancer
The latest in science and policy
Bacteria found in mosquito guts could help scientists fight dengue, Zika
Newly identified microbe disables the viruses before they can infect the insects, potentially reducing disease transmission in people
Daring ‘James Bond’ mission to drill Antarctic ices cores could reveal future of sea level rise
To understand vulnerable glaciers, climate scientists extract ice from continent’s remote and stormy coast
Charred bones are signs of Maya ritual to erase past rulers
Twelve-hundred-year-old burnt remains in Guatemala reflect political turmoil that led to the eventual collapse of empire
Striking Amazonian butterfly is result of ancient hybrid event
Matings between two species are often evolutionary dead ends. This one birthed a new species
Amid budget crunch, NASA seeks Hail Mary on Mars Sample Return
U.S. space agency calls for new proposals to reduce mission’s cost
Hiring ban disrupts research at Florida universities
Suit seeks to overturn state law targeting graduate and postdocs from China and other “countries of concern”
People with complicated pregnancies may suffer health problems, die early
Massive study finds long-term risks for those who experience preeclampsia, preterm delivery, and other complications
Octopus genetics study pushes back origin of sex chromosomes in animals
How cephalopods determine sex points to an even more ancient starting point for this trait
Messenger RNA technology shows first promise against a rare and deadly disease
“Milestone” Moderna trial finds fewer medical crises in some people with metabolic disorder after RNA infusions